Table 3 PCI procedural data and incidence of PMI in the BUDO and BUDAO groups.

From: Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)—a randomized trial

Variables

BUDO group (n = 165)

BUDAO group (n = 165)

P value

Pre-dilation

 PRDB MD (mm)

2.57 ± 0.32

2.53 ± 0.36

0.214

 PRDB length (mm)

13.93 ± 2.82

14.27 ± 3.11

0.293

 PRDB PRMP (atm)

13.32 ± 2.69

13.80 ± 3.19

0.143

 Pre-diated number

3.00 ± 1.05

2.85 ± 0.81

0.145

 Pre-diated TT (s)

9.98 ± 3.60

9.62 ± 2.82

0.317

Stent implantation

 Stent number

1.59 ± 0.72

1.48 ± 0.64

0.148

 Stent AD (mm)

3.07 ± 0.47

3.02 ± 0.42

0.256

 Stent TL (mm)

40.81 ± 21.49

38.38 ± 18.79

0.276

 Stent DMP (atm)

10.13 ± 1.99

9.98 ± 1.67

0.474

 Stent DTT (s)

6.36 ± 2.94

6.42 ± 2.29

0.835

Post-dilation

 PODB MD (mm)

3.25 ± 0.49

3.16 ± 0.48

0.110

 PODB length (mm)

12.12 ± 2.22

12.19 ± 2.26

0.769

 PODB POMP (atm)

18.80 ± 2.43

18.56 ± 2.53

0.376

 Post-dilated number

3.64 ± 1.05

3.45 ± 1.20

0.121

 Post-dilated TT (s)

12.27 ± 3.46

11.78 ± 3.31

0.190

During PCI

 IVUS use (%)

24 (14.55%)

20 (12.12%)

0.627

 IABP use (%)

2 (1.21%)

0 (0.00%)

0.498

 No/slow blood flow (%)

2 (1.21%)

4 (2.42%)

0.685

 Verapamil use (%)

1 (0.61%)

4 (2.42%)

0.371

 Tirofiban use (%)

1 (0.61%)

0 (0.00%)

1.000

 Operation time (min)

40.52 ± 24.72

43.22 ± 23.76

0.312

After PCI

 PMI (%)

115 (69.70%)

102 (61.82%)

0.164

 MPMI (%)

81 (49.09%)

70 (42.42%)

0.269

  1. Data were expressed as n (%), mean ± SD. PMI Procedural myocardial injury; PRDB Pre-dilated balloon; MD Maximal diameter; PRMP Pre-dilated maximal pressure; TT Total time; AD Average diameter; TL Total length; DMP Deployed maximal pressure; DTT Deployed total time; PODB Post-dilated balloon; POMP Post-dilated maximal pressure; IVUS Intravascular ultrasound; IABP Intra-aortic balloon pump; MPMI Major PMI.